Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

119.01
Delayed Data
As of Apr 24
 +0.29 / +0.24%
Today’s Change
47.03
Today|||52-Week Range
132.99
+22.69%
Year-to-Date

Today’s Trading

Previous close118.72
Today’s open118.04
Day’s range116.81 - 120.28
Volume322,919
Average volume (3 months)671,738
Market cap$10.0B
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-234.48%
Earnings growth (this year)+38.62%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales142.50
Price/Book9.79

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...+1.40+2.07%
ISISIsis Pharmaceuticals...-1.38-2.03%
ICLRICON PLC+0.44+0.63%
DYAXDyax Corp-0.85-3.00%
Data as of 4:05pm ET, 04/24/2015

Financials

Next reporting dateMay 4, 2015
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$50.6M
Annual profit (last year)-$360.4M
Net profit margin-712.79%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers